英格兰3-6岁儿童接种第四剂含无细胞百日咳疫苗后出现肢体大面积肿胀和全身症状
研究评估英格兰973名3-6岁儿童接种第四剂含无细胞百日咳疫苗后大面积肢体肿胀(ESL,肿胀直径>100mm)的频率。局部肿胀直径>50mm在TdaP/IPV组为2.2%,DTaP/IPV组为6.6-11.1%;13名儿童(1.3%)发生ESL,其中3名接种TdaP/IPV。ESL在数日内无全身不适自行缓解,通常无痛,仅2名儿童就医。
要点
- 局部肿胀直径>50mm在TdaP/IPV组为2.2%,DTaP/IPV组为6.6-11.1%。
- 13名儿童(1.3%)发生ESL,其中3名接种TdaP/IPV。
- ESL在数日内无全身不适自行缓解,通常无痛,仅2名儿童就医。
核心结论
- 含无细胞百日咳疫苗的学前加强针后ESL是一种良性、一过性状况,应告知家长其可能发生但可放心。
研究设计与样本
- 评估973名儿童接种第四剂含无细胞百日咳疫苗(联合灭活脊灰、破伤风及低剂量或高剂量白喉疫苗)后ESL的频率。
- 通过7天日记或电话随访记录接种后症状和局部反应。
主要发现
- 局部肿胀直径>50mm在TdaP/IPV组为2.2%,DTaP/IPV组为6.6-11.1%。
- 局部发红直径>50mm在TdaP/IPV组为7.0%,DTaP/IPV组为13.3-17.7%。
- 在DTaP/IPV疫苗中,添加Hib不影响局部反应频率或大小。
- 注射部位疼痛和全身症状在四个疫苗组间无差异。
- 特应性病史与局部肿胀或发红的发生无关。
临床怎么用
- 应告知家长学前含无细胞百日咳疫苗加强针后可能发生ESL,但可放心其为良性、一过性状况。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extensive limb swelling (ESL) after a booster dose of acellular pertussis (aP) containing vaccine can cause concern and has the potential to be confused with cellulitis. In the United Kingdom aP-containing vaccine was introduced for primary immunisation at 2, 3 and 4months of age in 2004, with the first cohorts eligible to receive a fourth dose in 2007 at school entry. We assessed the frequency of ESL (here defined as swelling >100mms diameter) in 973 children receiving a fourth dose of one of four aP vaccines given combined with inactivated polio, tetanus and either low dose diphtheria (TdaP/IPV) or high dose diphtheria (DTaP/IPV) vaccine; 2 of the 3 DTaP/IPV vaccines also contained Haemophilus influenza b conjugate vaccine (Hib). Post-vaccination symptoms and local reactions were recorded in 7-day diaries or by a telephone follow up if no diary was returned. Local swellings >50mm diameter were reported by 2.2% TdaP/IPV recipients compared with 6.6-11.1% of DTaP/IPV recipients; the corresponding proportions for redness >50mms was 7.0% for TdaP/IPV and 13.3-17.7% for DTaP/IPV recipients. Among the latter, the addition of Hib did not affect the frequency or size of local reactions. Pain at the injection site and systemic symptoms did not differ between the four vaccine groups. A history of atopy was not associated with development of local swelling or redness. A total of 13 children (1.3%) experienced an ESL, three after TdaP/IPV. ESLs resolved without systemic upset within a few days and were usually painless; medical advice was only sought for two children. Parents should be informed about the possible occurrence of an ESL with the pre-school aP-containing booster vaccine but can be reassured that it is a benign and transient condition.
引用
- Southern J, Waight PA, Andrews N, et al. Extensive swelling of the limb and systemic symptoms after a fourth dose of acellular pertussis containing vaccines in England in children aged 3-6years. Vaccine. 2016. PMID: 28017441. doi:10.1016/j.vaccine.2016.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。